Bill > A06087

This bill requires health insurance policies in New York to provide full coverage for multi-marker testing for patients diagnosed with an ovarian adnexal mass, which is a type of growth or mass in the area near the ovaries. Specifically, the bill mandates that all health insurance policies (including individual, group, and blanket policies) and medical service corporations must offer complete coverage for this specific type of cancer-related testing. The coverage must be provided without any annual deductibles or coinsurance, meaning the insurance company will bear the entire cost of the test. The bill applies to various types of health insurance providers, including hospital service corporations, medical expense indemnity corporations, and health service corporations. Additionally, the bill extends this coverage requirement to Medicaid. The new requirements will take effect on the first day of January following the bill's passage and will apply to any policies that are issued, renewed, modified, or amended after that date. Multi-marker testing is likely a diagnostic tool used to assess the potential presence or risk of ovarian cancer in patients with an ovarian adnexal mass.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A6087